| 1 |
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
|
|
Remuzzi Giuseppe, Schiaffino Stefano, Santoro Maria Gabriella, FitzGerald Garret A., Melino Gennaro, Patrono Carlo, Frontiers in Pharmacology
2022 13():.
doi:10.3389/fphar.2022.987816
|
| 2 |
Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia
|
|
Chen Chih-Hao, Chang Kuan-Cheng, Lin Yen-Nien, Ho Mao-Wang, Cheng Meng-Yu, Shih Wen-Hsin, Chou Chia-Huei, Lin Po-Chang, Chi Chih-Yu, Lu Min-Chi, Tien Ni, Wu Mei-Yao, Chang Shih-Sheng, Hsu Wu-Huei, Shyu Woei-Cheang, Cho Der-Yang, Jeng Long-Bin, Frontiers in Medicine
2022 9():.
doi:10.3389/fmed.2022.1001979
|
| 3 |
An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario
|
|
Gudadappanavar Anupama M., Benni Jyoti, Journal of Basic and Clinical Physiology and Pharmacology
2020 31(6):.
doi:10.1515/jbcpp-2020-0113
|
| 4 |
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients
|
|
Croci Stefania, Bonacini Martina, Dolci Giovanni, Massari Marco, Facciolongo Nicola, Pignatti Elisa, Pisciotta Alessandra, Carnevale Gianluca, Negro Aurelio, Cassone Giulia, Muratore Francesco, Belloni Lucia, Zerbini Alessandro, Salvarani Carlo, Frontiers in Cell and Developmental Biology
2021 8():.
doi:10.3389/fcell.2020.609204
|
| 5 |
Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention
|
|
Kumar Asit, Kodidela Sunitha, Tadrous Erene, Cory Theodore James, Walker Crystal Martin, Smith Amber Marie, Mukherjee Ahona, Kumar Santosh, Viruses
2020 12(8):887.
doi:10.3390/v12080887
|
| 6 |
Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells
|
|
Hernandez Jonathan J., Beaty Doyle E., Fruhwirth Logan L., Lopes Chaves Ana P., Riordan Neil H., Journal of Translational Medicine
2021 19(1):.
doi:10.1186/s12967-021-02813-6
|
| 7 |
Stem cell-derived biofactors fight against coronavirus infection
|
|
Ardalan Mohammadreza, Chodari Leila, Zununi Vahed Sepideh, Hosseiniyan Khatibi Seyed Mahdi, Eftekhari Aziz, Davaran Soodabeh, Cucchiarini Magali, Roshangar Leila, Ahmadian Elham, World Journal of Stem Cells
2021 13(12):1813.
doi:10.4252/wjsc.v13.i12.1813
|
| 8 |
Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
|
|
Gardin Chiara, Ferroni Letizia, Chachques Juan Carlos, Zavan Barbara, Journal of Clinical Medicine
2020 9(9):2762.
doi:10.3390/jcm9092762
|
| 9 |
PATHOGENETIC RATIONALE FOR THE USE OF D?ELL THERAPY IN LUNG INJURY ASSOCIATED WITH SARS-COV-2
|
|
Stukan A. I., Gilevich I. V., Porhanov V. A., Bodnya V. N., Innovative medicine of Kuban
2020 (2):69.
doi:10.35401/2500-0268-2020-18-2-69-78
|
| 10 |
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
|
|
Alzahrani Faisal A., Saadeldin Islam M., Ahmad Abrar, Kumar Dipak, Azhar Esam I., Siddiqui Arif Jamal, Kurdi Bassem, Sajini Abdulrahim, Alrefaei Abdulmajeed F., Jahan Sadaf, Stem Cells International
2020 2020():1.
doi:10.1155/2020/8835986
|
| 11 |
Systematic comparation of the biological and transcriptomic landscapes of human amniotic mesenchymal stem cells under serum-containing and serum-free conditions
|
|
Sun Yunyan, Wang Ti-er, Hu Qianwen, Zhang Wenxia, Zeng Yun, Lai Xun, Zhang Leisheng, Shi Mingxia, Stem Cell Research & Therapy
2022 13(1):.
doi:10.1186/s13287-022-03179-2
|
| 12 |
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
|
|
Gorman Ellen, Millar Jonathan, McAuley Danny, Oa??Kane Cecilia, Expert Review of Respiratory Medicine
2021 15(3):301.
doi:10.1080/17476348.2021.1848555
|
| 13 |
Mesenchymal stem cell research progress for the treatment of COVID-19
|
|
Yao Dezhi, Ye Huanrong, Huo Zhirong, Wu Lei, Wei Shixiong, Journal of International Medical Research
2020 48(9):030006052095506.
doi:10.1177/0300060520955063
|
| 14 |
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
|
|
Raman Renuka, Patel Krishna J., Ranjan Kishu, Biomolecules
2021 11(7):993.
doi:10.3390/biom11070993
|
| 15 |
Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
|
|
Esquivel Diana, Mishra Rangnath, Soni Prabhat, Seetharaman Rajasekar, Mahmood Anjum, Srivastava Anand, Stem Cell Reviews and Reports
2021 17(1):144.
doi:10.1007/s12015-020-10017-6
|
| 16 |
Emerging therapeutics in the management of COVID-19
|
|
Kichloo Asim, Albosta Michael, Kumar Akshay, Aljadah Michael, Mohamed Mohamed, El-Amir Zain, Wani Farah, Jamal Shakeel, Singh Jagmeet, Kichloo Akif, World Journal of Virology
2021 10(1):1.
doi:10.5501/wjv.v10.i1.1
|
| 17 |
Treatment of COVID-19 with MSCs: how does it work?
|
|
Keating Armand, Science China Life Sciences
2022 65(4):849.
doi:10.1007/s11427-021-2022-5
|
| 18 |
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment
|
|
Huang Yuling, Li Xin, Yang Lina, Stem Cell Research & Therapy
2022 13(1):.
doi:10.1186/s13287-022-03034-4
|
| 19 |
Dimethyl Fumarate Can Enhance the Potential Therapeutic Effects of Epidermal Neural Crest Stem Cells in COVID-19 Patients
|
|
Safari Anahid, Khodabandeh Zahra, Borhani-Haghighi Afshin, Stem Cell Reviews and Reports
2021 17(1):300.
doi:10.1007/s12015-020-10094-7
|
| 20 |
Redressing the interactions between stem cells and immune system in tissue regeneration
|
|
Fang Jiankai, Feng Chao, Chen Wangwang, Hou Pengbo, Liu Zhanhong, Zuo Muqiu, Han Yuyi, Xu Chenchang, Melino Gerry, Verkhratsky Alexei, Wang Ying, Shao Changshun, Shi Yufang, Biology Direct
2021 16(1):.
doi:10.1186/s13062-021-00306-6
|
| 21 |
Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature
|
|
Cuevas-Gonzalez Mar?-a Ver?3nica, Garcia-Perez ??lvaro, Gonzalez-Aragon Pineda ??lvaro Edgar, Espinosa-Cristobal Le?3n Francisco, Donohue-Cornejo Alejandro, Tovar-Carrillo Karla Lizette, Saucedo-Acu?±a Rosa Alicia, Cuevas-Gonzalez Juan Carlos, Sun Fengjie, BioMed Research International
2021 2021():1.
doi:10.1155/2021/9915927
|
| 22 |
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
|
|
Iacob Simona, Iacob Diana Gabriela, Frontiers in Pharmacology
2020 11():.
doi:10.3389/fphar.2020.01224
|
| 23 |
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients
|
|
Yi??eno??lu Tu???§e Nur, Ba??c?± Semih, ??ahin Derya, Ula?? Turgay, Dal Mehmet Sinan, Korkmaz Serdal, Hac?±bekiro??lu Tuba, Namdaro??lu Sinem, Erkurt Mehmet Ali, Turgut Burhan, Altunta?? Fevzi, Transfusion and Apheresis Science
2021 60(6):103237.
doi:10.1016/j.transci.2021.103237
|
| 24 |
Cytokine Storm of COVID-19 and its Impact on Patients with and without Chronic Liver Disease
|
|
Premkumar Madhumita, Kedarisetty Chandan Kumar, Journal of Clinical and Translational Hepatology
2021 000(000):000.
doi:10.14218/JCTH.2021.00055
|
| 25 |
Stem cell therapy in coronavirus disease 2019: current evidence and future potential
|
|
Shetty Rohit, Murugeswari Ponnalagu, Chakrabarty Koushik, Jayadev Chaitra, Matalia Himanshu, Ghosh Arkasubhra, Das Debashish, Cytotherapy
2021 23(6):471.
doi:10.1016/j.jcyt.2020.11.001
|
| 26 |
Therapeutic Agents Against COVID-19 with Clinical Evidence
|
|
Tian Cheng, Xiang Ming, Current Pharmaceutical Design
2021 27(13):1608.
doi:10.2174/1381612827666210114150951
|
| 27 |
Preventive and treatment strategies of COVID-19: From community to clinical trials
|
|
Sahu KamalKant, Kumar Raman, Journal of Family Medicine and Primary Care
2020 9(5):2149.
doi:10.4103/jfmpc.jfmpc_728_20
|
| 28 |
Nanoconjugates-Based Stem Cell Therapy for the Management of COVID-19
|
|
Desai Drashti, Shende Pravin, Stem Cell Reviews and Reports
2021 17(1):231.
doi:10.1007/s12015-020-10079-6
|
| 29 |
ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis
|
|
Wei Jinhuan, Shang Rui, Wang Jiaqi, Zhu Shengze, Yin JianQiang, Chen Ying, Zhao Yayu, Chen Gang, iScience
2022 25(4):104046.
doi:10.1016/j.isci.2022.104046
|
| 30 |
COVIDa??19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
|
|
Askenase Philip W., Journal of Extracellular Vesicles
2020 10(1):.
doi:10.1002/jev2.12004
|
